Falcon Oil & Gas Ltd. - Another Stellar IP30 Flow Test Result in the Beetaloo
Falcon Oil & Gas Ltd ('Falcon').
Another Stellar IP30 Flow Test Result in the Beetaloo
16 June 2025 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to announce that Shenandoah S2-2H ST1 ('SS-2H ST1') achieved an average 30-day initial production ('IP30') flow rate of 7.2 million cubic feet per day ('MMcf/d') over 1,671-metres (5,483-foot) across a 35 stage stimulated length within the Amungee Member B-Shale in the Beetaloo Sub-basin, Northern Territory, Australia, making it the highest IP30 result in the Beetaloo to date.
Points to note:
The normalized flow rate of 13.2 MMcf/d over an extrapolated 10,000-foot horizontal section is in-line with the average of more than 11,000 wells in the Marcellus Shale dry gas area on production over a 12-month period. The results demonstrate the commercial deliverability of gas from the Amungee Member B-Shale in the Australian East Coast gas market that typically sells at a premium to Henry Hub in the United States and under long term CPI-linked contracts.
The exit rate trajectory continues a steady, low-declining curve at 6.7 MMcf/d (normalized at 12.2 MMcf/d per 10,000-feet) with a flowing wellhead pressure of ~910 psi. The steady state decline curve on SS-2H ST1 is consistent with that achieved from the Shenandoah South 1H well ('SS-1H').
For further details on the SS-2H ST1 flow test including a table, and charts please refer to Appendix A.
Development activity
The Shenandoah South drilling campaign is planned to commence in July 2025, targeting up to three 10,000-foot horizontal wells and completed with up to 60 stimulation stages from the SS2 well pad. As previously announced, Falcon Oil & Gas Australia Limited ('Falcon Australia') has opted to reduce its participating interest in the three wells to 0%.
Once completed, the five wells on the SS2 pad are planned to be tied into the Sturt Plateau Compression Facility ('SPCF') to feed into a 40 MMcf/d take-or-pay Gas Sales Agreement ('GSA') with the Northern Territory Government. Production remains on track to commence in mid-2026, subject to standard regulatory and stakeholder approvals and favourable weather conditions.
The Shenandoah South 4H ('SS-4H') well is planned to be completed and flow tested by the end of 2025, with the remaining wells drilled in the 2025 campaign to be completed during 1H 2026.
Completion of the remaining four wells will incorporate lessons from the SS-1H and SS-2H ST1 wells.
The five wells are expected to deliver the required 40 MMcf/d volume under a binding take-or-pay agreement with the Northern Territory Government.
Philip O'Quigley, CEO of Falcon commented:
'The IP30 flow rate results announced today of 7.2 MMcf/d, are truly stellar and marks another major data point in the Beetaloo Sub-basin again demonstrating that it compares to the best shale wells in the United States. Not only did the results exceed Falcon's pre-drill commercial threshold of a normalised flow rate of 3 MMcf/d per 1,000 metres but had similar flow rates and pressures to SS-1H and SS-2H ST1, which all point towards the significant resource potential of the Beetaloo.
Falcon looks forward to the planned completion and testing of SS-4H by the end of 2025 and also to observing the results from the next three wells of the Shenandoah South drilling program and the additional milestones they will establish.
As further results become available, we look forward to updating the market further'
Ends.
CONTACT DETAILS:
Falcon Oil & Gas Ltd.
+353 1 676 8702
Philip O'Quigley, CEO
+353 87 814 7042
Anne Flynn, CFO
+353 1 676 9162
Cavendish Capital Markets Limited (NOMAD & Broker)
Neil McDonald / Adam Rae
+44 131 220 9771
This announcement has been reviewed by Dr. Gábor Bada, Falcon Oil & Gas Ltd's Technical Advisor. Dr. Bada obtained his geology degree at the Eötvös L. University in Budapest, Hungary and his PhD at the Vrije Universiteit Amsterdam, the Netherlands. He is a member of AAPG.
About Falcon Oil & Gas Ltd. Falcon Oil & Gas Ltd is an international oil & gas company engaged in the exploration and development of unconventional oil and gas assets, with the current portfolio focused in Australia. Falcon Oil & Gas Ltd is incorporated in British Columbia, Canada and headquartered in Dublin, Ireland.
Falcon Oil & Gas Australia Limited is a c. 98% subsidiary of Falcon Oil & Gas Ltd.
For further information on Falcon Oil & Gas Ltd. Please visit www.falconoilandgas.com
About Beetaloo Joint Venture (EP 76, 98 and 117)
Company
Interest
Falcon Oil & Gas Australia Limited (Falcon Australia)
22.5%
Tamboran (B2) Pty Limited ('Tamboran')
77.5%
Total
100.0%
Shenandoah South Pilot Project -2 Drilling Space Units – 46,080 acres
Company
Interest
Falcon Oil & Gas Australia Limited (Falcon Australia)
5.0%
Tamboran (B2) Pty Limited
95.0%
Total
100.0%About Tamboran (B2) Pty LimitedTamboran (B1) Pty Limited ('Tamboran B1') is the 100% holder of Tamboran (B2) Pty Limited, with Tamboran B1 being a 50:50 joint venture between Tamboran Resources Corporation and Daly Waters Energy, LP.
Tamboran Resources Corporation is a natural gas company listed on the NYSE (TBN) and ASX (TBN). Tamboran is focused on playing a constructive role in the global energy transition towards a lower carbon future, by developing the significant low CO2 gas resource within the Beetaloo Sub-basin through cutting-edge drilling and completion design technology as well as management's experience in successfully commercialising unconventional shale in North America.
Bryan Sheffield of Daly Waters Energy, LP is a highly successful investor and has made significant returns in the US unconventional energy sector in the past. He was Founder of Parsley Energy Inc. ('PE'), an independent unconventional oil and gas producer in the Permian Basin, Texas and previously served as its Chairman and CEO. PE was acquired for over US$7 billion by Pioneer Natural Resources Company.
Appendix A - SS-2H ST1 Flow Test Details
Note to reader: Please refer to the PDF attachment included at the end of this press release for further details including a table and charts related to the SS-2H ST1 flow test results
Advisory regarding forward-looking statementsCertain information in this press release may constitute forward-looking information. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking information. Forward-looking information typically contains statements with words such as 'may', 'will', 'should', 'expect', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'projects', 'dependent', 'consider' 'potential', 'scheduled', 'forecast', 'anticipated', 'outlook', 'budget', 'hope', 'suggest', 'support' 'planned', 'approximately', 'potential' or the negative of those terms or similar words suggesting future outcomes. In particular, forward-looking information in this press release includes, details on the IP30 flow test results of SS-2H ST1 including assumptions that the results are in line with average of more than 11,000 wells in the Marcellus Shale dry gas area on production over a 12-month period and that they demonstrate the commercial deliverability of gas from the Amungee Member B-Shale in the Australian East Coast gas market that typically sells at a premium to Henry Hub in the United States and under long term CPI-linked contracts; consistency of the results of SS-2H ST1 with SS-1H; details on the planned three well drilling campaign including the plan to commence in July 2025 and to continue into 1H 2026; the plan to tie the wells to the SPCF under a GSA with the Northern Territory Government in mid-2026; the plan that SS-4H will be completed and flow tested by the end of 2025; the five wells drilled are expected to deliver the required 40 MMcf/d under a GSA with the Northern Territory Government;
This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. The risks, assumptions and other factors that could influence actual results include risks associated with fluctuations in market prices for shale gas; risks related to the exploration, development and production of shale gas reserves; general economic, market and business conditions; substantial capital requirements; uncertainties inherent in estimating quantities of reserves and resources; extent of, and cost of compliance with, government laws and regulations and the effect of changes in such laws and regulations; the need to obtain regulatory approvals before development commences; environmental risks and hazards and the cost of compliance with environmental regulations; aboriginal claims; inherent risks and hazards with operations such as mechanical or pipe failure, cratering and other dangerous conditions; potential cost overruns, drilling wells is speculative, often involving significant costs that may be more than estimated and may not result in any discoveries; variations in foreign exchange rates; competition for capital, equipment, new leases, pipeline capacity and skilled personnel; the failure of the holder of licenses, leases and permits to meet requirements of such; changes in royalty regimes; failure to accurately estimate abandonment and reclamation costs; inaccurate estimates and assumptions by management and/or their joint venture partners; effectiveness of internal controls; the potential lack of available drilling equipment; failure to obtain or keep key personnel; title deficiencies; geo-political risks; and risk of litigation.
Readers are cautioned that the foregoing list of important factors is not exhaustive and that these factors and risks are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Falcon assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to Falcon. Additional information identifying risks and uncertainties is contained in Falcon's filings with the Canadian securities regulators, which filings are available at www.sedarplus.com, including under "Risk Factors" in the Annual Information Form.
Any references in this news release to initial production rates are useful in confirming the presence of hydrocarbons; however, such rates are not determinative of the rates at which such wells will continue production and decline thereafter and are not necessarily indicative of long-term performance or ultimate recovery. While encouraging, readers are cautioned not to place reliance on such rates in calculating the aggregate production for Falcon. Such rates are based on field estimates and may be based on limited data available at this time.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain.
Attachment
061625 Final Falcon Press Release - SS-2H ST1 IP30 v2
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Excite Media Launches Data-Driven Employee Engagement Strategy to Great Success
Brisbane, Australia, June 25, 2025 -- Digital marketing agency Excite Media has implemented a data-driven approach to employee engagement, using the Employee Net Promoter Score (eNPS) as a key business metric to enhance workplace culture, improve retention, and strengthen client delivery. Founded in 2006 by Scott Maynard and Nathanael Hubbard, Excite Media has prioritized workplace culture as a strategic lever for performance. The company has integrated regular employee feedback into its operations using Officevibe, an employee engagement platform that administers anonymous, weekly surveys. These insights inform internal initiatives aimed at improving communication, recognition, and work-life balance. Nathanael Hubbard, Co-Founder of Excite Media, says, 'We use data to understand how our team is feeling and take meaningful steps based on that feedback.' The Employee Net Promoter Score methodology, developed by Bain & Company, asks employees to rate how likely they are to recommend their workplace to friends or family. Responses are grouped into promoters, passives, and detractors, and the score is calculated accordingly. Excite Media consistently targets an eNPS score of 80, a benchmark associated with top-performing organizations globally. What distinguishes Excite Media's approach is its commitment to acting on survey insights. Leadership reviews trends and patterns on a weekly basis and takes steps to address emerging concerns. This commitment to transparency and responsiveness has fostered a high-trust environment where employees feel heard and valued. The company reports that this process has contributed to high retention rates and consistent client satisfaction, reinforcing its belief that employee engagement is directly tied to business performance. For more information, visit About Excite Media Founded in 2006 and headquartered in Brisbane, Australia, Excite Media is a digital marketing agency that provides website design, SEO, Google Ads management, and content marketing services. The company is known for its commitment to employee engagement and workplace culture as drivers of long-term business success. Contact Info: Name: Scott Maynard Email: Send Email Organization: Excite Media Website: Release ID: 89163177 If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
Yahoo
3 hours ago
- Yahoo
QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) patients with advanced Soft Tissue Sarcoma (STS). An Objective Response Rate (ORR) of 80% was achieved, based on the Best Observed Response (BOR) at any time during the study, indicating 8 out of 10 evaluable patients saw either complete ablation (100% reduction in volume) or partial ablation (≥30% reduction in volume) of treated tumours. 22 of the 27 (81%) injected tumours across all patients showed complete or partial ablation (14 showing complete ablation and 8 showing partial ablation). None of the 14 completely ablated tumours recurred at 6 months, indicating tigilanol tiglate may provide durable responses. QBiotics Group Limited (QBiotics) is pleased to announce final efficacy and safety data from the first of its two stage, Phase IIa clinical trial in patients with Soft Tissue Sarcoma (STS). STS is a rare type of cancer that generally forms as a painless lump (tumour) in any one of the soft tissues in the body. There were approximately 128,000 new cases of STS globally in 2023, with the incidence growing at 0.54% per year.[1] QBiotics' CEO and Managing Director, Stephen Doyle commented, "We are delighted with the outcomes from Stage 1 of our Phase IIa Soft Tissue Sarcoma trial. Tigilanol tiglate met both its primary and secondary endpoints and delivered patients an impressive 80% Objective Response Rate in injected tumours. Importantly, none of the 14 fully ablated (destroyed) tumours had recurred by the 6-month follow-up period, suggesting tigilanol tiglate may provide long-term benefit for patients. Given soft tissue sarcoma is a challenging cancer to treat, achieving this level of clinical activity is highly encouraging." "Our thanks to every trial patient, and also to the trial Investigators, Dr. Edmund Bartlett and his team at Memorial Sloan Kettering Cancer Center in New York. Given the positive results from Stage 1 of the trial – and compelling investigator reports that tigilanol tiglate may improve responses to systemic therapies in metastatic STS – we have moved ahead with the expansion arm of the study, announced late last year." Dr. Edmund Bartlett, Principal Trial Investigator at Memorial Sloan Kettering Cancer Center commented, "The clinical activity of tigilanol tiglate, which we observed in multiple types of soft tissue sarcoma, was encouraging. I look forward to expanding our experience with this treatment and determining how to integrate it into the care of patients with soft tissue sarcoma." ABOUT TRIAL QB46C-H07 QB46C-H07 (Clinical trial registration, NCT05755113) is a Phase IIa, open label, clinical trial evaluating the preliminary efficacy and safety of intratumoural tigilanol tiglate in patients with a range of advanced and/or metastatic STS. QB46C-H07 is being conducted in two stages: Stage 1 is a pilot trial in 10 patients. Stage 2 is an expansion trial. The results of Stage 1 are reported here. Eleven patients were administered tigilanol tiglate (0.5 mg tigilanol tiglate/cm3 tumour volume) to one or more of their tumours. Ten patients were included in the response evaluable population (where patients had a tumour assessment at both baseline and at 28 days post-treatment). The primary efficacy endpoint was Objective Response Rate (ORR) of injected tumours, compared to baseline. ORR was defined as the proportion of patients who achieved complete ablation (100% reduction in volume) or partial ablation (≥ 30% reduction in volume) of treated tumours and/or tumour segments following one or more treatments (up to 5 treatments) with tigilanol tiglate. Patients who achieved a ≥ 30% reduction in volume, irrespective of the number of treatments they received, were considered to have a response to tigilanol tiglate. Secondary endpoints include safety and tolerability assessments, and pharmacokinetics. Exploratory endpoints include local rate of recurrence at the injection site at 6 months post-initial injection, and assessment of tumour response in biopsy samples. Surgical specimens and blood samples were used to assess changes in tumour biomarkers. Efficacy and Safety Outcomes The ORR was 80% indicating 8 out of 10 evaluable patients achieved either complete or partial ablation of their treated tumours or tumour segments at any time during the study (Best Observed Response, BOR). There was a median of 2 treatments of tigilanol tiglate per patient (range 1 to 5). At the tumour level, 22 of 27 (81%) treated tumours showed either complete or partial responses as the Best Observed Response. 14 out of 27 tumours (52%) demonstrated complete ablation, while 8 out of 27 tumours (30%) demonstrated partial ablation. These results indicate a high level of efficacy for tigilanol tiglate in achieving complete or partial tumour ablation. Importantly, none of the complete responses (n=14) recurred by 6 months, the follow-up period, indicating tigilanol tiglate may provide durable responses. All 11 tigilanol tiglate treated patients were included in the safety evaluation. Tigilanol tiglate was well tolerated. Most of the Adverse Events (AEs) were expected and related to the local action of the drug (e.g. local pain, swelling, necrosis). Conclusions Overall, the study results indicate tigilanol tiglate is well tolerated and shows promising efficacy in reducing tumour volume, with 80% of patients experiencing complete (100%) ablation or partial (≥30%) ablation of their tumours. The absence of tumour recurrence in cases achieving a complete response further underscores tigilanol tiglate's potential as an effective treatment option for soft tissue sarcomas and possibly other solid tumours. The promising tumour responses reported here, together with observations that three patients exhibited better than expected responses to subsequent systemic therapy (as presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting in November 2024),[2] have supported the progression of the QB46C-H07 study to Stage 2. The trial expansion (referred to as Stage 2) aims to further investigate the clinical utility and therapeutic potential of tigilanol tiglate in patients with STS. Stage 2 of the trial is opening shortly at Memorial Sloan Kettering Cancer Center in New York, USA. References GlobalData®, American Cancer Society, Cancer Australia, Cancer Research UK, Canadian Cancer Society. Bartlett et al, 2024. The Connective Tissue Oncology Society (CTOS) Annual Meeting, Nov 13-16, 2024, San Diego, USA. NOTES FOR EDITORS ABOUT QBIOTICS QBiotics is an unlisted, public, Australian life sciences company that seamlessly connects scientific discovery, development and commercialisation to harness the power of nature to treat diseases of high unmet need. Our current clinical focus is on novel treatments for cancer and debilitating chronic wounds. We also have an early-stage antibiotics program. QBiotics' lead molecule, tigilanol tiglate, is a novel, small molecule with the potential to treat a broad range of solid tumours. It is currently in Phase II clinical trials in two indications: soft tissue sarcoma (STS) and head and neck cancer (HNC). Tigilanol tiglate was granted Orphan Drug Designation by the US FDA for the treatment of STS in February 2024. A veterinary formulation of tigilanol tiglate (STELFONTA®) is approved for the treatment of canine mast cell tumours (MCTs), in major global markets, including the USA, Europe, and Australia. QBiotics has partnered with Virbac, a global animal health company, to distribute STELFONTA®. Our wound healing drug candidate, EBC-1013, is a small molecule, which targets multiple pathways to accelerate healing, improving outcomes in chronic and acute wounds and burns. A first-in-human Phase I clinical trial in venous leg ulcers is open for recruitment. For more, head to: or LinkedIn. View original content to download multimedia: SOURCE QBiotics Group Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Washington Post
3 hours ago
- Washington Post
Sunsets, sheep and safari tents: Life on an Australian farmstay
SPICERS CREEK, Australia The scent of rain floods the yellowing countryside, quieting bleating sheep and sending kangaroos bolting for cover. Thick drops thud on the roof of Mountview Camp, a palatial two-bedroom canvas tent perched on a ridge at Budgalong, a 7,000-acre farm in this former goldmining town less than 200 miles west of Sydney. The drive to the farmstay from the front gate is two miles up a steep winding track that crosses five livestock grates and leaves behind a plume of chalky pink dust. My tent is filled with luxury amenities and rural necessities: a snake-bite kit within reaching distance of the linen-topped queen bed, a steel teapot beside a biscuit jar filled with buttery shortbread, rainwater feeding wide showerheads in tiled bathrooms. 'Farming is a way of life,' says Nick Sutherland, a third-generation sheep farmer and Budgalong's manager. 'The adventure starts when you get here.' Story continues below advertisement Advertisement The Sutherlands have farmed crops and livestock in the craggy, eucalyptus-filled hills of Spicers Creek since 1959. This 630-acre patch is scrubby grazing territory for 120 of the farm's 13,000 sheep and, recently, home to two custom-designed, self-contained farmstays, Mountview included. The family is among a growing group of Australian farmers investing in agritourism, providing travelers with an experience that demonstrates the physical labor, environmental management and beautiful scenery that make up life on the land. Agritourism combines elements synonymous with the Australian identity: world-renowned produce and viticulture, exceptional geological beauty, and the boisterous culture of mateship. CSIRO, Australia's national scientific research organization, predicts agritourism will contribute $18.6 billion to the economy by 2030. It's a method to bring visitors to regional and rural Australia as much as it is an educational tool, sharing the journey from paddock — as it were — to plate. Georgina Simson watches the sun set on a commercial farm in Premer, Australia, on March 18. Sheep are seen in a pasture near Budgalong Lodge in Spicers Creek on March 20. Agritourism allows travelers to experience rural life in Australia. The sun sets at Budgalong. Australian growers are susceptible to some of the most chaotic, unpredictable and catastrophic weather in the world, and they are often hamstrung by market pricing. Agritourism allows farmers to diversify income, sell direct to consumers and broaden understanding of farming communities. Much of Australia sits behind closed gates and cattle grates. The landmass is more than 50 percent farmland, and the average farm is 10.6 acres; Australia's largest farms are closer to 6,000 square miles, which is more than 3.8 million acres. From July 2023 through June 2024, 777,000 of overnight visitors in Victoria, a state in southeastern Australia, sought out farms for on-site farm-gate shopping, overnight experiences and agricultural activities, according to Visit Victoria, the state's tourism body. From inside the tarped walls at Mountview, flyscreened 'windows' zipper down to reveal ghost gum trees and moss-covered ancient shale. The world outside is tangible and accessible, and yet my seclusion is intentional and complete. The fridge is stocked with succulent cutlets from Sutherland's lambs and staples from neighboring pork, egg and dairy producers. When I cook the cutlets later that night, the lamb tastes as vibrant and robust as the Australian landscape it grazed. The honey I spoon into my tea — left on the counter with a handwritten label after being harvested from hives nearby — reminds me of the scent of Australian wildflowers. Nick Sutherland's 7,000-acre farm in Spicers Creek features large herds of sheep. From my viewing perch (an oversize, waxed-canvas beanbag on the deck), I can hear satisfied moos as cows scratch on fences and am absorbed watching lambs follow ewes through well-worn tracks in the grasslands. Distant from the urban centers and other people, I exhale. The impatient rain pauses as quickly as it appears. Late-afternoon sunlight turns the horizon shades of magenta that match the endemic pink galah bird's chest. Wind whistles through the towering gums. Beyond the distant green-gold ripples of Coolah Tops National Park and the Warrumbungle mountain ranges, half a rainbow appears. 'The farming lifestyle and what happens on the land — you don't understand it until you experience it,' Sutherland says. '[Staying for a weekend] might just be a small little taste of that.' Fairfield Camp at Budgalong, which is on the Sutherland's family farm. Local cheese and wine, homemade cookies, and honey from the farm are stocked for guests at Budgalong. Sutherland checks on his sheep. The sun rises over Mountview, located on the Sutherland's family farm. At Budgalong, guests can observe the rugged landscape, wander secluded trails, watch livestock and consume the bounty of the land. At other farms around the country, visitors might ride horses, pluck berries and camp beneath the cosmos. These stays take customers up close and personal with ringers, jillaroos and stockmen (Australia's cowboys, cowgirls and farmhands) as they round up livestock or harvest. Agritourism casts a wide net, spanning from cellar door trails in Victoria's Rutherglen wine region, fruit-picking experiences at Cape Trib Farm in the country's northeast, and aquaculture experiences, such as shucking tours at Melshell Oysters, on Tasmania's east coast. Travelers can enjoy remote luxury stays at the 400,000-acre conservation-driven Bullo River Station in the Northern Territory (NT), a night at a farm's eco-lodge in Western Australia (WA), or BYO tent to camp in designated paddocks found on sites such as Hipcamp. Story continues below advertisement Advertisement It is not without challenges, however: Australia has long faced extreme weather events and suffers from connectivity black spots, labor shortages, imperfect regional infrastructure and poorly maintained roads. Distance between properties can be a matter of days, not miles, with limited resources between far-flung towns. Regional action groups, farming communities and individual operators are embracing the yonder, deeming it a chance to collaborate and craft bespoke experiences that give travelers a resason to journey far and stay for longer. Cattle are moved at Tommerup's Dairy Farm in Queensland on March 17. Dave Tommerup closes a gate after moving cattle at Tommerup's Dairy Farm. Chickens provide fresh eggs at Tommerup's Dairy Farm in Queensland. Multiday regional festivals such as Taste Great Southern in WA, Tasting Australia in South Australia, Tasmania's Tasting Trail and the self-drive New South Wales (NSW) Northern Rivers Harvest Food Trail guide travelers to properties they might otherwise miss, connecting multiple farming operations and food businesses for consumers. 'We've learned that people want what you have on a farm and they don't necessarily want you to change who you are or what you do,' says Kay Tommerup, co-owner of Tommerup's Dairy Farm in Queensland's Scenic Rim, one hour inland from Brisbane. Tommerup has watched agritourism bloom since her family diversified their sixth-generation dairy and mixed-farming property. National milk prices were deregulated in 2000, and pivoting into agritourism — starting with milking experiences and tours — saved the 150-year-old business. Tommerup farm is a working dairy, with market days, buttermaking classes, long lunches and barn dances. 'You'll never get the experience of real Australia if you don't step onto somebody's farm and meet a farmer, shake their hand and eat what they produce,' says Tommerup, who is also president of nonprofit Agritourism Queensland. 'There's nothing that can compare to that in Australia: that genuine connection.' Georgina Simson at the Plantation, a 32,123-acre commercial farm in New South Wales, on March 19. Florence Simson sits on her pony at the Plantation. World Farmers' Organization Vice President Fiona Simson and her husband, Ed, recently handed over operations of the Plantation, their 32,123-acre farm in the Liverpool Plains of NSW to their son Tom and daughter-in-law Georgina, who has been the impetus behind driving the family business into agritourism. The property is halfway between Tamworth, Australia's country music capital, and Mudgee, a major wine region. After the catastrophic 2019 drought (which saw the hottest, driest conditions in 120 years and two years of the lowest rainfall on record), the Simsons took part in a regional, post-Covid-lockdown sunflower trail and welcomed 5,000 visitors over eight weeks. They now host farm tours and paddock lunches for inland-rail visitors and plan to add overnight stays in the future. Georgina Simson said most of the farmers who get into agritourism aren't trying to make it a big business. They're sharing something they love. 'If you get talking to any farmer, they're very passionate about what they do,' she says. 'Once they get going, they won't stop.' Tom Simson works in a sorghum field at the Plantation. Kangaroos pass by the Plantation. Tom and Georgina Simson look at vegetation on the Plantation, which they run. Tom Simson works in a sorghum field at The Plantation. A horse stands on the Plantation. Online platforms such as Farmers Stays, WA Station Stays and Harvest Trails & Markets are making it easier to find such farmers. Before launching Farmer Stays in 2021, founder Eliza Sanby spent time on farms in Queensland, WA and the NT. The platform lists over 100 properties — including Budgalong and McKeown's Rest at Kenzell Farm, a 250-acre farm and homestead at Jenolan Caves in NSW, that hosts hands-on camel feeding, donkey brushing, farm stewardship lessons and milking, as well as the chance to stay overnight. The successful marriage of agricultural advocacy and entrepreneurship is epitomized in Tasmania, the triangular island of wilderness at the bottom of Australia. The state is 25 percent farmland, 34 percent national park and Australia's largest aquaculture producer. In 2020, 60 small- to large-scale farmers developed agritourism offerings and 30 established operators fine-tuned theirs as part of the two-year Opening the Gate program. Allison Clark, a former Huon Valley orchardist and the executor of the project, says the program highlighted agritourism's four cores: people, product, passion and place. 'It's not just giving the keys to a shearer's shed and saying, 'Here you go and stay there for the night,'' she says. 'It's about providing an experience that connects the farmer and the visitor … the passion of the farmer and why they do what they do.' The night sky over Mountview at Budgalong.
